Chemours EPS History: Annual & Quarterly (CC)
Chemours's diluted EPS was -$2.57 for fiscal 2025.
View full Chemours company overviewChemours annual diluted eps history
| Fiscal year | Period ended | Diluted EPS | Basic EPS | Change | Growth |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | -$2.57 | -$2.57 | -$3.03 | — |
| 2024 | 2024-12-31 | $0.46 | $0.46 | $2.16 | — |
| 2023 | 2023-12-31 | -$1.70 | -$1.70 | -$5.35 | — |
| 2022 | 2022-12-31 | $3.65 | $3.72 | $0.05 | +1.39% |
| 2021 | 2021-12-31 | $3.60 | $3.69 | $2.28 | +172.73% |
| 2020 | 2020-12-31 | $1.32 | $1.33 | $1.64 | — |
| 2019 | 2019-12-31 | -$0.32 | -$0.32 | -$5.77 | — |
| 2018 | 2018-12-31 | $5.45 | $5.62 | $1.54 | +39.39% |
| 2017 | 2017-12-31 | $3.91 | $4.04 | $3.87 | +9675.00% |
| 2016 | 2016-12-31 | $0.04 | $0.04 | $0.54 | — |
| 2015 | 2015-12-31 | -$0.50 | -$0.50 | -$2.71 | — |
| 2014 | 2014-12-31 | $2.21 | $2.21 | -$0.13 | −5.56% |
| 2013 | 2013-12-31 | $2.34 | $2.34 | — | — |
Chemours quarterly diluted eps
| Fiscal quarter | Period ended | Diluted EPS | Basic EPS | Change | YoY change |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | -$1.81 | -$1.81 | $0.72 | — |
| Q1 2026 | 2026-03-31 | -$0.19 | -$0.19 | -$0.16 | — |
| Q4 2025 | 2025-12-31 | -$0.31 | -$0.31 | -$0.23 | — |
| Q3 2025 | 2025-09-30 | $0.31 | $0.31 | $0.53 | — |
| Q2 2025 | 2025-06-30 | -$2.53 | -$2.53 | -$2.92 | — |
| Q1 2025 | 2025-03-31 | -$0.03 | -$0.03 | -$0.39 | — |
| Q4 2024 | 2024-12-31 | -$0.08 | -$0.08 | $0.04 | — |
| Q3 2024 | 2024-09-30 | -$0.22 | -$0.22 | -$0.30 | — |
| Q2 2024 | 2024-06-30 | $0.39 | $0.40 | $2.91 | — |
| Q1 2024 | 2024-03-31 | $0.36 | $0.36 | -$0.60 | −62.50% |
| Q4 2023 | 2023-12-31 | -$0.12 | -$0.12 | $0.53 | — |
| Q3 2023 | 2023-09-30 | $0.08 | $0.08 | -$1.44 | −94.74% |
| Q2 2023 | 2023-06-30 | -$2.52 | -$2.52 | -$3.78 | — |
| Q1 2023 | 2023-03-31 | $0.96 | $0.97 | -$0.47 | −32.87% |
| Q4 2022 | 2022-12-31 | -$0.65 | -$0.65 | — | — |
| Q3 2022 | 2022-09-30 | $1.52 | $1.54 | $0.25 | +19.69% |
| Q2 2022 | 2022-06-30 | $1.26 | $1.29 | $0.87 | +223.08% |
| Q1 2022 | 2022-03-31 | $1.43 | $1.46 | $0.86 | +150.88% |
| Q3 2021 | 2021-09-30 | $1.27 | $1.30 | $0.81 | +176.09% |
| Q2 2021 | 2021-06-30 | $0.39 | $0.40 | $0.24 | +160.00% |
| Q1 2021 | 2021-03-31 | $0.57 | $0.58 | -$0.04 | −6.56% |
| Q3 2020 | 2020-09-30 | $0.46 | $0.46 | $0.00 | 0.00% |
| Q2 2020 | 2020-06-30 | $0.15 | $0.15 | -$0.42 | −73.68% |
| Q1 2020 | 2020-03-31 | $0.61 | $0.61 | $0.06 | +10.91% |
| Q4 2019 | 2019-12-31 | -$1.94 | -$1.94 | -$2.75 | — |
| Q3 2019 | 2019-09-30 | $0.46 | $0.46 | -$1.05 | −69.54% |
| Q2 2019 | 2019-06-30 | $0.57 | $0.58 | -$0.96 | −62.75% |
| Q1 2019 | 2019-03-31 | $0.55 | $0.56 | -$1.03 | −65.19% |
| Q4 2018 | 2018-12-31 | $0.81 | $0.83 | -$0.38 | −31.93% |
| Q3 2018 | 2018-09-30 | $1.51 | $1.56 | $0.43 | +39.81% |
| Q2 2018 | 2018-06-30 | $1.53 | $1.58 | $0.69 | +82.14% |
| Q1 2018 | 2018-03-31 | $1.58 | $1.63 | $0.79 | +100.00% |
| Q4 2017 | 2017-12-31 | $1.19 | $1.23 | $2.45 | — |
| Q3 2017 | 2017-09-30 | $1.08 | $1.12 | -$0.03 | −2.70% |
| Q2 2017 | 2017-06-30 | $0.84 | $0.87 | $0.94 | — |
| Q1 2017 | 2017-03-31 | $0.79 | $0.82 | $0.51 | +182.14% |
| Q4 2016 | 2016-12-31 | -$1.26 | -$1.26 | -$0.78 | — |
| Q3 2016 | 2016-09-30 | $1.11 | $1.12 | $1.27 | — |
| Q2 2016 | 2016-06-30 | -$0.10 | -$0.10 | $0.00 | — |
| Q1 2016 | 2016-03-31 | $0.28 | $0.28 | $0.04 | +16.67% |
| Q4 2015 | 2015-12-31 | -$0.48 | -$0.48 | -$0.92 | — |
| Q3 2015 | 2015-09-30 | -$0.16 | -$0.16 | -$0.75 | — |
| Q2 2015 | 2015-06-30 | -$0.10 | -$0.10 | -$0.74 | — |
| Q1 2015 | 2015-03-31 | $0.24 | $0.24 | -$0.30 | −55.56% |
| Q4 2014 | 2014-12-31 | $0.44 | $0.44 | — | — |
| Q3 2014 | 2014-09-30 | $0.59 | $0.59 | — | — |
| Q2 2014 | 2014-06-30 | $0.64 | $0.64 | — | — |
| Q1 2014 | 2014-03-31 | $0.54 | $0.54 | — | — |
Chemours diluted eps trends
Over the last five fiscal years, Chemours's diluted eps decreased from $1.32 to -$2.57, a change of -$3.89. The latest reported quarter, Q2 2026, shows -$1.81.
What earnings per share (EPS) means
Earnings per share (EPS) shows how much profit or loss is attributable to each common share. Diluted EPS includes the potential effect of convertible securities, options, and other instruments that could increase the share count, while basic EPS uses the weighted-average common shares actually outstanding.
SEC-reported diluted and basic EPS
TickerStat displays diluted and basic earnings per share from SEC filings. Historical EPS values are adjusted to the current share basis when SEC-reported stock-split conversion ratios are available; they are not analyst estimates or earnings forecasts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Chemours source filings ↗Community posts
Chemours, DuPont and Corteva agree to a $455 million PFAS settlement
Chemours ($CC), DuPont ($DD) and Corteva ($CTVA) reached an agreement to resolve PFAS-related claims brought by North Carolina and 11 local government entities. The settlement provides for $455 million in nominal payments over 15 years. Che ...